1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Canada Haematology Market Outlook to 2021

Canada Haematology Market Outlook to 2021

  • August 2015
  • -
  • Global Data
  • -
  • 55 pages

Canada Haematology Market Outlook to 2021

Summary

GlobalData’s new report, "Canada Haematology Market Outlook to 2021", provides key market data on the Canada Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Haematology market.
- Global corporate-level profiles of key companies operating within the Canada Haematology market.
- Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Canada Haematology Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Haematology Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Haematology Market, Canada 9
3.1 Haematology Market, Canada, Revenue ($m), 2007-2014 9
3.2 Haematology Market, Canada, Revenue ($m), 2014-2021 11
3.2.1 Haematology Cell Counters Market, Canada, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Haematology Rapid Tests and POC Market, Canada, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Haematology Reagents Market, Canada, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Haemostasis Market, Canada, Revenue ($m), by Segment, 2007-2014 19
3.2.5 Immunohaematology Market, Canada, Revenue ($m), by Segment, 2007-2014 21
3.2.6 Haematology Cell Counters Market, Canada, Revenue ($m), by Segment, 2014-2021 23
3.2.7 Haematology Rapid Tests and POC Market, Canada, Revenue ($m), by Segment, 2014-2021 25
3.2.8 Haematology Reagents Market, Canada, Revenue ($m), by Segment, 2014-2021 27
3.2.9 Haemostasis Market, Canada, Revenue ($m), by Segment, 2014-2021 29
3.2.10 Immunohaematology Market, Canada, Revenue ($m), by Segment, 2014-2021 31
3.3 Haematology Market, Canada, Distribution Share by Revenue ($m), 2013-2014 33
3.4 Haematology Market, Canada, Company Share by Revenue ($m), 2014 34
4 Overview of Key Companies in Canada, Haematology Market 36
4.1 Siemens Healthcare 36
4.1.1 Company Overview 36
4.2 Danaher Corporation 36
4.2.1 Company Overview 36
4.3 Sysmex Corporation 36
4.3.1 Company Overview 36
4.4 Abbott Laboratories 36
4.4.1 Company Overview 36
4.5 F. Hoffmann-La Roche Ltd. 37
4.5.1 Company Overview 37
4.6 Bio-Rad Laboratories, Inc. 37
4.6.1 Company Overview 37
4.7 bioMerieux S.A. 37
4.7.1 Company Overview 37
4.8 Immucor, Inc. 38
4.8.1 Company Overview 38
4.9 Horiba, Ltd. 38
4.9.1 Company Overview 38
4.10 Biomedica Diagnostics Inc. 38
4.10.1 Company Overview 38
4.11 Diagnostica Stago, Inc. 38
4.11.1 Company Overview 38
4.12 Grifols, S.A. 39
4.12.1 Company Overview 39
5 Haematology Market Pipeline Products 40
6 Financial Deals Landscape 41
6.1 Partnerships 41
6.1.1 Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 41
6.1.2 NoemaLife Enters into Distribution Agreement with Horiba Medical 42
7 Recent Developments 43
7.1 Corporate Communications 43
7.1.1 Sep 04, 2014: Amorfix appoints Dr Elliot Goldstein and Mr Warren Whitehead to Board of Directors 43
7.1.2 Aug 20, 2014: Amorfix announces retirement of Dr. Hans Black 43
7.2 Financial Announcements 44
7.2.1 May 25, 2015: Amorfix Announces Financial Results for First Quarter 2015 44
7.2.2 Mar 31, 2015: Amorfix Announces Financial Results For Nine-month Period Ended December 31, 2014 45
7.2.3 Mar 12, 2015: Cardiorenal Benefits of Aortix Device to be Presented at ACC.15 in San Diego, CA 46
7.2.4 Nov 12, 2014: Amorfix announces second quarter results for period ending September 30, 2014 48
7.3 Other Significant Developments 50
7.3.1 Jul 14, 2015: ProMIS Neurosciences announces that it has effected its name change to ProMIS Neurosciences on July 8, 2015 and shares will begin trading under the new name on July 14, 2015 50
7.3.2 Mar 16, 2015: Amorfix Board authorizes exploration of strategic alternatives 50
8 Appendix 52
8.1 Research Methodology 53
8.1.1 Coverage 53
8.1.2 Secondary Research 53
8.1.3 Primary Research 54
8.1.4 Company Share Analysis 54
8.1.5 Distribution Share Analysis 54
8.2 GlobalData Consulting 54
8.3 Contact Us 55
8.4 Disclaimer 55

1.1 List of Tables
Table 1: Haematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Haematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Haematology Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Haemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 20
Table 7: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 22
Table 8: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Haematology Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Table 10: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Table 11: Haemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Table 12: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Table 13: Haematology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 33
Table 14: Haematology Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 35
Table 15: Haematology Market Pipeline Products 40
Table 16: Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 41
Table 17: NoemaLife Enters into Distribution Agreement with Horiba Medical 42

1.2 List of Figures
Figure 1: Haematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Haematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Haematology Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Haemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 19
Figure 7: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 21
Figure 8: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Haematology Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 25
Figure 10: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Figure 11: Haemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Figure 12: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Figure 13: Haematology Market, Canada, Company Share (%) 2014 34

Companies Mentioned
Siemens Healthcare
Danaher Corporation
Sysmex Corporation
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories, Inc.
bioMerieux S.A.
Immucor, Inc.
Horiba, Ltd.
Biomedica Diagnostics Inc.
Diagnostica Stago, Inc.
Grifols, S.A.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

U.S. Hemostasis Diagnostics Market: Analyzer and Reagent Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities

U.S. Hemostasis Diagnostics Market: Analyzer and Reagent Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities

  • $ 6200
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200. Summary This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.